Elena Trombettoni2022-10-05T11:20:42+00:00September 28th, 2022|Categories: Medical Research, Meditrial|
Historically, patient organizations have had the primary purpose of supporting the communities they represented. Today, this remains a crucial function, but modes have changed, as has the role that associations and patients themselves take on in clinical research. The WHO [...]
Elena Trombettoni2022-09-28T16:04:24+00:00September 28th, 2022|Categories: AboutPharma|
In collaborazione con Aboutpharma Storicamente, le organizzazioni dei pazienti hanno avuto lo scopo primario di supportare le comunità che rappresentavano. Oggi questa rimane una funzione cruciale ma le modalità sono cambiate, come anche il ruolo che le [...]
Elena Trombettoni2022-09-28T11:02:03+00:00September 21st, 2022|Categories: Medical Research, Meditrial|
Dr. Paola Antonini, Meditrial Scientific Director All clinical trials benefit from oversight, which is currently provided by regulatory authorities, Ethics Committees or Institutional Review Boards, and Data Monitoring Committees (Dmc), also sometimes referred to as Data Safety Monitoring [...]
Elena Trombettoni2022-09-28T11:03:04+00:00September 21st, 2022|Categories: AboutPharma|
D.ssa Paola Antonini, direttore scientifico Meditrial - IN COLLABORAZIONE CON ABOUTPHARMA Tutti gli studi clinici beneficiano di supervisione, che attualmente è fornita dalle autorità regolatorie, dai Comitati Etici o dalle Institutional Review Board, e dalle Data [...]
e.alvarado2022-09-28T10:10:51+00:00September 15th, 2022|Categories: AboutPharma|
Paola Antonini, direttore scientifico Meditrial - IN COLLABORAZIONE CON MEDITRIAL Si stima che oltre il 90% degli studi clinici fallisca a causa di un limitato reclutamento dei pazienti, inefficienze dello sperimentatore, insufficiente comprensione degli aspetti etici e [...]
Elena Trombettoni2022-09-28T10:21:58+00:00September 15th, 2022|Categories: Medical Research, Meditrial|
Paola Antonini, Meditrial Scientific Director. It is estimated that more than 90% of clinical trials fail due to limited patient recruitment, investigator inefficiencies, insufficient understanding of local ethical and regulatory aspects, site and region selected for conducting the [...]
Elena Trombettoni2022-09-16T16:01:49+00:00September 7th, 2022|Categories: Medical Research, Meditrial|
Dr.ssa Paola Antonini, Meditrial scientific director The International medical device regulators forum (Imdrf), describes Software as a Medical Device (SaMD) as software that can run on generic (non-medical) computing platforms. They can be used in conjunction with other [...]
Elena Trombettoni2022-09-16T19:54:37+00:00September 7th, 2022|Categories: AboutPharma|
Dr.ssa Paola Antonini, direttore scientifico Meditrial - IN COLLABORAZIONE CON MEDITRIAL. L’International medical device regulators forum (Imdrf), descrive i SaMD (Software as a Medical Device (SaMD) come software che possono funzionare su piattaforme informatiche generiche (non [...]
Elena Trombettoni2022-09-16T15:54:02+00:00September 1st, 2022|Categories: Medical Research, Meditrial|
Dr.ssa Paola Antonini, Meditrial scientific director In recent years, the field of biomarkers in research and clinical practice has shown remarkable progress. These tests can be used in the screening, diagnosis, characterization, and monitoring of diseases; as prognostic [...]
e.alvarado2022-09-16T19:54:06+00:00August 31st, 2022|Categories: AboutPharma|
Dr.ssa Paola Antonini, direttore scientifico Meditrial Negli ultimi anni il settore dei biomarker nella ricerca e nella pratica clinica ha presentato notevoli progressi. Questi test possono essere utilizzati nello screening, nella diagnosi, nella caratterizzazione e [...]
Become part of Meditrial! Subscribe to our newsletter.
Meditrial Europe - VAT CHE-115.033.718 © 2009 - 2024 | All Rights Reserved | Privacy | Terms of Use | Advertising Policy
